» Articles » PMID: 23381943

Ischemic Stroke is Associated with the ABO Locus: the EuroCLOT Study

Abstract

Objective: End-stage coagulation and the structure/function of fibrin are implicated in the pathogenesis of ischemic stroke. We explored whether genetic variants associated with end-stage coagulation in healthy volunteers account for the genetic predisposition to ischemic stroke and examined their influence on stroke subtype.

Methods: Common genetic variants identified through genome-wide association studies of coagulation factors and fibrin structure/function in healthy twins (n = 2,100, Stage 1) were examined in ischemic stroke (n = 4,200 cases) using 2 independent samples of European ancestry (Stage 2). A third clinical collection having stroke subtyping (total 8,900 cases, 55,000 controls) was used for replication (Stage 3).

Results: Stage 1 identified 524 single nucleotide polymorphisms (SNPs) from 23 linkage disequilibrium blocks having significant association (p < 5 × 10(-8)) with 1 or more coagulation/fibrin phenotypes. The most striking associations included SNP rs5985 with factor XIII activity (p = 2.6 × 10(-186)), rs10665 with FVII (p = 2.4 × 10(-47)), and rs505922 in the ABO gene with both von Willebrand factor (p = 4.7 × 10(-57)) and factor VIII (p = 1.2 × 10(-36)). In Stage 2, the 23 independent SNPs were examined in stroke cases/noncases using MOnica Risk, Genetics, Archiving and Monograph (MORGAM) and Wellcome Trust Case Control Consortium 2 collections. SNP rs505922 was nominally associated with ischemic stroke (odds ratio = 0.94, 95% confidence interval = 0.88-0.99, p = 0.023). Independent replication in Meta-Stroke confirmed the rs505922 association with stroke, beta (standard error, SE) = 0.066 (0.02), p = 0.001, a finding specific to large-vessel and cardioembolic stroke (p = 0.001 and p = < 0.001, respectively) but not seen with small-vessel stroke (p = 0.811).

Interpretation: ABO gene variants are associated with large-vessel and cardioembolic stroke but not small-vessel disease. This work sheds light on the different pathogenic mechanisms underpinning stroke subtype.

Citing Articles

Additive association of blood group A allele with 15 cardiometabolic diseases: a UK Biobank life-course study.

Zhao R, Xian W, Ma Y, Napolioni V, Lau P, Tian X Cardiovasc Diabetol. 2025; 24(1):113.

PMID: 40065387 PMC: 11895148. DOI: 10.1186/s12933-025-02669-w.


The Investigation of the Distribution of ABO/Rh Blood Group in Hospitalized COVID-19 Patients and Its Association With Disease Severity, Clinical Outcomes, Lab Tests, and Radiologic Findings.

Zendehdel A, Asoodeh A, Ansari M, JamaliMoghaddamsiyahkali S Health Sci Rep. 2025; 8(2):e70250.

PMID: 39931255 PMC: 11808318. DOI: 10.1002/hsr2.70250.


Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged.

Chen R, Wang X, Li N, Golubnitschaja O, Zhan X EPMA J. 2024; 15(3):415-452.

PMID: 39239108 PMC: 11371995. DOI: 10.1007/s13167-024-00376-2.


Non-O blood types are associated with a greater risk of large artery atherosclerosis stroke and dysregulation of cholesterol metabolism: an observational study.

Gou L, Li H, Jiang Y, Liu Y, Gu H, Xu Z Lipids Health Dis. 2024; 23(1):211.

PMID: 38965603 PMC: 11223365. DOI: 10.1186/s12944-024-02199-6.


COVID-19 host genetics and ABO blood group susceptibility.

Ellinghaus D Camb Prism Precis Med. 2024; 1:e10.

PMID: 38550941 PMC: 10953747. DOI: 10.1017/pcm.2022.12.


References
1.
Ionescu D, Marcu I, Bicescu E . Cerebral thrombosis, cerebral haemorrhage, and ABO blood-groups. Lancet. 1976; 1(7954):278-80. DOI: 10.1016/s0140-6736(76)91405-7. View

2.
Suhre K, Shin S, Petersen A, Mohney R, Meredith D, Wagele B . Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011; 477(7362):54-60. PMC: 3832838. DOI: 10.1038/nature10354. View

3.
Freeman M, Mansfield M, Barrett J, Grant P . Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability. Arterioscler Thromb Vasc Biol. 2002; 22(3):506-10. DOI: 10.1161/hq0302.104906. View

4.
Carter A, Cymbalista C, Spector T, Grant P . Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol. 2007; 27(12):2783-9. DOI: 10.1161/ATVBAHA.107.153221. View

5.
Reilly M, Li M, He J, Ferguson J, Stylianou I, Mehta N . Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011; 377(9763):383-92. PMC: 3297116. DOI: 10.1016/S0140-6736(10)61996-4. View